VBI Vaccines Inc. (VBIV)
After hours:
| Previous close | 0.6297 |
| Open | 0.6400 |
| Bid | 0.6004 x 100 |
| Ask | 0.6711 x 100 |
| Day's range | 0.6080 - 0.6533 |
| 52-week range | 0.4500 - 3.4700 |
| Volume | |
| Avg. volume | 456,096 |
| Market cap | 18.018M |
| Beta (5Y monthly) | 1.92 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.0300 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.00 |
Business WireVBI Vaccines Reports Full Year 2023 Financial Results
CAMBRIDGE, Mass., April 16, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the year ended December 31, 2023.
Business WireVBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CAMBRIDGE, Mass., April 11, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 2,272,728 of its common shares and warrants to purchase up to 2,272,728 common shares, at an offering price of $0.88 per common share and associated warrant. The warrants have an exercise
Business WireVBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
CAMBRIDGE, Mass., April 09, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that it has entered into definitive agreements for the sale and issuance of 2,272,728 common shares (or pre-funded warrants in lieu thereof) of VBI at an offering price of $0.88 per common share (or per pre-funded warrant in lieu thereof), in a registered direct offering priced at-the-market unde
